Table S1.
Categorized causes of deaths due to VEGFR-TKIs
| Causes | VEGFR-TKIs (%) | Control (%) |
|---|---|---|
| Hemorrhage | 5 (4.6) | 4 (8.9) |
| Cerebrovascular accident | 5 (4.6) | 2 (4.4) |
| Renal failure | 1 (0.9) | 0 (0) |
| Neutropenia | 5 (4.6) | 0 (0) |
| Thromboembolism | 9 (8.3) | 3 (6.7) |
| Pulmonary disorders | 4 (3.7) | 6 (13.3) |
| Sudden death | 3 (2.8) | 0 (0) |
| Sepsis | 5 (4.6) | 2 (4.4) |
| Cardiopulmonary insufficiency | 12 (11.1) | 5 (11.1) |
| Hepatic failure | 5 (4.6) | 1 (2.2) |
| Gastrointestinal diseases | 7 (6.5) | 0 (0) |
| Other | 4 (3.7) | 6 (13.3) |
| Unknown | 43 (39.8) | 16 (35.6) |
| Total | 108 (100) | 45 (100) |
Abbreviation: VEGFR-TKIs, vascular endothelial growth factor receptor tyrosine kinase inhibitors.